Status:
COMPLETED
Behavior Cognitive Therapy on Fatigue Impact in MS Patients
Lead Sponsor:
Réseau Sep Idf Ouest
Conditions:
Relapsing Remitting Multiple Sclerosis
Fatigue
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is a chronic inflammatory disease that leads to demyelination of the central nervous system. Fatigue is one of the most frequent and most disabling symptoms of MS. Up to 86% of...
Detailed Description
In spite of the fatigue impact is well known in MS, medical care of this symptom is not usual. Moreover, treatments of fatigue are available, but evidence for effectiveness is limited. This study will...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- RRMS
- EDSS ≤ 5,5
- MFIS score \> 45
- Outpatient treatment
- Enable to follow the BCT sessions
- French understanding
- More than 18 years old
- Inform consent signature
- Membership in a social protection
- Exclusion criteria
- Cognitive disorders avoiding patient participation
- Relapse within last 3 months before baseline
- Onset of DMT within 3 months
- Onset of antidepressive treatment within 3 months
- Onset of treatment for fatigue within 3 months
- Psychiatric disorders
Exclusion
Key Trial Info
Start Date :
May 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03758820
Start Date
May 31 2017
End Date
October 15 2020
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poissy St Germain Hospital
Poissy, France, 78300